Smile. That's the title of Mae Cleveland's colorful painting that won Best Overall Artwork in Signature HealthCARE's recent "Reflect N Us" competition.
The approval of Biogen Idec's MS therapy Tecfidera follows months of breathless Wall Street hype, and it looks like doctors are psyched for the drug, too. In a MedLIVE PULSE survey conducted by WorldOne Interactive, 40% of U.S neurologists polled said they're currently warehousing patients in anticipation of the new multiple sclerosis drug.
Government agencies and lobbyists are famous for conducting studies that prove a point — theirs, namely. That's why I'll be very interested to see who will have the courage to conduct one of the most important long-term care-related studies that should be completed over the coming year.
It's not a secret that employees who work in healthcare, whether they are medical journalists or nurses, don't always earn gold stars when it comes to managing their own health. Witness the nurses clustering in a "butt hut" outside a facility, an administrator taking a cavalier approach to his or her diet, or saleswomen wearing sole-killing heels at a conference.
A recent randomized trial showed that marijuana extract pills may help some patients with multiple sclerosis. Apparently, body pain, spasms, and other outcomes responded positively to the cannabis pills. However, there were associated side effects.
Federal health officials have agreed to changes in Medicare coverage rules that would make it easier for beneficiaries with chronic conditions to qualify for nursing home stays, outpatient therapy and home healthcare services, according to reports.
Botox (botulinum toxin type A) can be injected for certain types of urinary incontinence, the Food and Drug Administration said Wednesday.